Brain Tumor - Metastatic
9
4
4
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease
Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors
Research on the Safety and Efficacy of Intraoperative Radiation Therapy in Malignant Cerebral Tumor
Clinical Feasibility of Brain Radiotherapy Using Synthetic CTs in an MRI-only Workflow
Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases
Comparing Immobilisation Shells in Cranial Radiotherapy
Comparison of Hypertonic Saline and Mannitol on Brain Relaxation During Supratentorial Tumors Resection